PlainRecalls
FDA Drug Moderate Class II Terminated

Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01

Reported: October 23, 2019 Initiated: September 19, 2019 #D-0143-2020

Product Description

Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01

Reason for Recall

Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.

Details

Recalling Firm
Aurobindo Pharma USA Inc.
Units Affected
11,129 100-count bottles
Distribution
Nationwide in the US
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01. Recalled by Aurobindo Pharma USA Inc.. Units affected: 11,129 100-count bottles.
Why was this product recalled?
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 23, 2019. Severity: Moderate. Recall number: D-0143-2020.